Results 151 to 160 of about 4,835,110 (353)

The diagnosis of esophageal cancer using the radioactive phosphorus (32P)

, 1972
Mitsuo Endo
openalex   +2 more sources

Optimal Extent of Lymph Node Dissection for Non‐Metastatic Colon Cancer by Tumor Location: Evaluation of the Therapeutic Value Index for Each Lymph Node Station

Annals of Gastroenterological Surgery, EarlyView.
Lymph node dissection of the main nodes along the feeding artery has a therapeutic value in early‐stage colon cancers. Meanwhile, the significance of #253 dissection for descending colon cancer requires further discussion. ABSTRACT Aims To determine the optimal extent of lymph node dissection for non‐metastatic colon cancer by tumor location based on ...
Akira Ouchi, Kozo Kataoka, Eiji Shinto, Takashi Akiyoshi, Takefumi Yoshida, Yasuyuki Takamizawa, Yukihide Kanemitsu, Hirotoshi Kobayashi, Yoichi Ajioka, on behalf of the Lymph Nodes Committee of JSCCR   +9 more
wiley   +1 more source

The Present Condition of the Diagnostic and the Therapeutic Procedures of the Esophageal Cancer in Our Hospital

, 1974
Masaki Endo
openalex   +2 more sources

Prognostic Impact of Bone Mineral Density Reduction During Neoadjuvant Chemotherapy (NAC) in Patients Undergoing NAC Followed by Esophagectomy for Esophageal Cancer

Annals of Gastroenterological Surgery, EarlyView.
The association between BMD reduction during NAC and the worse prognosis remains unknown, although NAC followed by esophagectomy is a standard treatment for advanced ESCC. This study appeared that BMD massive reduction was an independent prognostic factor on OS (HR, 3.30; 95% confidence interval [CI], 1.69–6.55) and RFS (HR, 2.08; 95% CI, 1.19–3.63 ...
Kazuhide Sato, Keita Takahashi, Yoshitaka Ishikawa, Naoko Fukushima, Takahiro Masuda, Takanori Kurogochi, Masami Yuda, Akira Matsumoto, Kazuto Tsuboi, Yuichiro Tanishima, Fumiaki Yano, Ken Eto   +11 more
wiley   +1 more source

POSTOPERATIVE NUTRITIONAL CARE WITH THE ENTERAL AND THE PARENTERAL ROUTE FOR THE ESOPHAGEAL CANCER

, 1977
Masahiro Tsuboi, Michitaka MORITHO, Ryo YAGO, Makoto Okano, M Kawanishi, A Chiba, Ryoichi Motoki, K Honda   +7 more
openalex   +2 more sources

Esophageal cancer

Annals of Cardiothoracic Surgery, 2017
Christopher, Harris, Beth, Croce, Stine, Munkholm-Larsen   +2 more
openaire   +3 more sources

Influence of Facility Size on Perioperative Outcomes in Minimally Invasive Esophagectomy for 14 152 Patients With Esophageal Cancer Based on the Japanese National Clinical Database: A Multicenter Cohort Study

Annals of Gastroenterological Surgery, EarlyView.
This multicenter study investigated 14 152 minimally invasive esophagectomies (MIEs) using data from the Japanese National Clinical Database and showed a significantly lower operative mortality rate in high‐volume centers than in low‐volume centers. However, no differences in morbidity rates were found between facility sizes.
Taro Oshikiri, Hisateru Tachimori, Hiroaki Miyata, Yoshihiro Kakeji, Ken Shirabe   +4 more
wiley   +1 more source

Survival Outcomes of Esophageal Squamous Cell Carcinoma Patients Who Underwent Salvage Esophagectomy: A Literature Review and Results From Two High‐Volume Centers

Annals of Gastroenterological Surgery, EarlyView.
This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in 69 patients who underwent R0 salvage surgery for esophageal squamous cell carcinoma. Of note, abdominal LN metastases had a negative impact on survival in our series.
Kotaro Sugawara, Koichi Yagi, Takashi Fukuda, Shoh Yajima, Daiji Oka, Yoshiyuki Miwa, Shuichiro Oya, Asami Okamoto, Raito Asaoka, Yoshifumi Baba   +9 more
wiley   +1 more source

Parenteral Nutrition in Esophageal Cancer Patients

, 1982
J.M. Daly, E Massar, Geoffrey G. Giacco, O. HOWARD FRAZIER, Clifton F. Mountain, Stanley J. Dudrick, Edward M. Copeland   +6 more
openalex   +2 more sources

Long‐Term Survival of Two Versus Three Courses of Preoperative Cisplatin and Fluorouracil Plus Docetaxel for Locally Advanced Esophageal Cancer: A Multicenter Randomized Phase II Trial

Annals of Gastroenterological Surgery, EarlyView.
This multi‐institutional, randomized, phase II trial aimed to investigate the long‐term survival outcomes of two versus three courses of DCF for locally advanced esophageal squamous cell carcinoma (ESCC). The 5‐year overall survival and progression‐free survival rates for the three and two course groups were 70.7% vs. 63.8% (hazard ratio (HR) = 0.91, p 
Takahito Sugase, Hiroshi Miyata, Takashi Kanemura, Norihiro Matsuura, Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Kotaro Yamashita, Kota Momose, Osamu Shiraishi, Keijiro Sugimura, Masaaki Motoori, Kazumasa Fujitani, Atsushi Takeno, Motohiro Hirao, Yutaka Kimura, Taroh Satoh, Masahiko Yano, Yuichiro Doki, Takushi Yasuda   +19 more
wiley   +1 more source